The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry
Open accessAbstract
IMPORTANCE: Despite the frequency of atrial fibrillation (AF) in clinical practice, relatively little is known about sex differences in symptoms and quality of life and how they may affect treatment and outcomes. OBJECTIVE: To determine whether symptoms, quality of life, treatment, and outcomes differ between women and men with AF. DESIGN, SETTING, AND PARTICIPANTS: This observational cohort study included 10 135 patients with AF. The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation is a prospective, nationwide, multicenter outpatient registry of patients with incident and prevalent AF enrolled at 176 sites between June 2010 and August 2011. MAIN OUTCOMES AND MEASURES: Symptoms, quality of life as measured by Atrial Fibrillation Effects on Quality of Life scores, AF treatment, cardiovascular outcomes, stroke or non-central nervous system embolism, and all-cause mortality. RESULTS: Overall, 4293 of the cohort (42%) were female. Compared with men, women were older (77 years; interquartile range [IQR], 69-83, vs 73 years; IQR, 65-80; P < .001) and had higher median CHA2DS2-VASc scores (5; IQR, 4-6, vs 3; IQR, 2-5; P < .001), but less sleep apnea (578 [13.5%] vs 1264 [21.6%]; P < .001). Only 32.1% of women (n = 1378) were asymptomatic (European Heart Rhythm Association class I) compared with 42.5% of men (n = 2483) in unadjusted analyses (P < .001). Women had lower (more severe) unadjusted baseline overall Atrial Fibrillation Effects on Quality of Life scores (n = 2007; 80; IQR, 62-92 vs 83; IQR, 69-94; P < .001). Women had similar rates of anticoagulation and similar time in therapeutic range. In follow-up, women experienced lower risk-adjusted all-cause mortality (adjusted hazard ratio, 0.57; 95% CI, 0.49-0.67) and cardiovascular death (adjusted hazard ratio, 0.56; 95% CI, 0.44-0.72); however, they had a higher risk for stroke or non-central nervous system embolism (adjusted hazard ratio, 1.39; 95% CI, 1.05-1.84; P = .02) compared with men. CONCLUSIONS AND RELEVANCE: Women with AF have more symptoms and worse quality of life. Despite higher risk, women have lower risk-adjusted all-cause and cardiovascular death compared with men, but higher stroke rates. Future studies should focus on how treatment and interventions specifically affect AF-related quality of life and cardiovascular outcomes in women. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01165710.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Littell, R. C., Milliken, G. A., Stroup, W. W., Wolfinger, R. D., & Schabenberger, O. (2006) · CERN Document Server (European Organization for Nuclear Research) · Cited by 2,924
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr488 · Cited by 1,192 · cited 1×
“Time with INR < 2, median (IQR) 18 (8-31) 17 (7-30) .”
Dorian, P., Jung, W., Newman, D., Paquette, M., Wood, K., Ayers, G. M., Camm, J., Akhtar, M., & Luderitz, B. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00886-x · Cited by 627
Piccini, J. P., Hammill, B. G., Sinner, M. F., Jensen, P. N., Hernandez, A. F., Heckbert, S. R., Benjamin, E. J., & Curtis, L. H. (2012) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.962688 · Cited by 565
Self-citationSpertus, J., Dorian, P., Bubien, R., Lewis, S., Godejohn, D., Reynolds, M. R., Lakkireddy, D. R., Wimmer, A. P., Bhandari, A., & Burk, C. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.958033 · Cited by 485
Self-citationNovo, S., Rubio, J. S., Desideri, A., Mantovani, D., Rossi, D., Lombardi, F., Coppola, G., Garcia, J. A. B., Meloni, M., & Martinez, V. B. (2010) · Default journal · Cited by 434
Dagres, N., Nieuwlaat, R., Vardas, P. E., Andresen, D., Lévy, S., Cobbe, S., Kremastinos, D. T., Breithardt, G., Cokkinos, D. V., & Crijns, H. J. G. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.047 · Cited by 421
Weaver, W. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530340041027 · Cited by 257
Freeman, J. V., Simon, D. N., Go, A. S., Spertus, J., Fonarow, G. C., Gersh, B. J., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Thomas, L. E., et al. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001303 · Cited by 246
Self-citationLip, G. Y. H., Laroche, C., Ioachim, P. M., Rasmussen, L. H., Vitali-Serdoz, L., Petrescu, L., Darabantiu, D., Crijns, H. J. G. M., Kirchhof, P., Vardas, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu374 · Cited by 237 · cited 2×
“Time with INR < 2, median (IQR) 18 (8-31) 17 (7-30) .”
Gender-Related Differences in Rhythm Control Treatment in Persistent Atrial Fibrillation
Rienstra, M., Van Veldhuisen, D. J., Hagens, V. E., Ranchor, A. V., Veeger, N. J. G. M., Crijns, H. J. G. M., & Van Gelder, I. C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.078 · Cited by 230
Zusterzeel, R., Selzman, K. A., Sanders, W. E., Caños, D. A., O’Callaghan, K. M., Carpenter, J. L., Piña, I. L., & Strauss, D. G. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.2717 · Cited by 214
Piccini, J. P., Fraulo, E. S., Ansell, J., Fonarow, G. C., Gersh, B. J., Go, A. S., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Thomas, L. E., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.07.001 · Cited by 154
Self-citationHeuzey, J. L., BREITHARDT, G. E., Camm, A. J., Crijns, H. J. G. M., Dorian, P., Kowey, P. R., Merioua, I., Prystowsky, E. N., Schwartz, P. J., Torp-Pedersen, C. T., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.012 · Cited by 109
Self-citationLip, G. Y. H., Rushton-Smith, S. K., Goldhaber, S. Z., Fitzmaurice, D. A., Mantovani, L. G., Goto, S., Haas, S. K., Bassand, J., Camm, A. J., Ambrosio, G., et al. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001556 · Cited by 95
Angina at 1 Year After Myocardial Infarction Prevalence and Associated Findings
Maddox, T. M., Reid, K. J., Spertus, J. A., Mittleman, M., Krumholz, H. M., Parashar, S., Ho, P. M., & Rumsfeld, J. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.12.1310 · Cited by 90
Self-citationTsadok, M. A., Gagnon, J., Joza, J. E., Behlouli, H., Verma, A., Essebag, V., & Pilote, L. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.06.029 · Cited by 80
Ha, A. C. T., BREITHARDT, G. E., Camm, A. J., Crijns, H. J. G. M., Fitzmaurice, G. M., Kowey, P. R., Heuzey, J. L., Naditch‐Brûlé, L., Prystowsky, E. N., Schwartz, P. J., et al. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000011 · Cited by 75
Self-citationvon Eisenhart Rothe, A., Hutt, F., Baumert, J., Breithardt, G., Goette, A., Kirchhof, P., & Ladwig, K.-H. (2015) · Europace · doi:10.1093/europace/euv018 · Cited by 63 · cited 1×
“Time with INR < 2, median (IQR) 18 (8-31) 17 (7-30) .”
Locati, E. H., Vecchi, A. M., Vargiu, S., Cattafi, G., & Lunati, M. (2013) · EP Europace · doi:10.1093/europace/eut337 · Cited by 57
Reiffel, J. A., Kowey, P. R., Myerburg, R. J., Naccarelli, G. V., Packer, D. L., Pratt, C. M., Reiter, M. J., & Waldo, A. L. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.11.046 · Cited by 44
Self-citationBarrionuevo, J. D. D. A., Barón‐Esquivias, G., Martínez, Á. M., Cornejo, J. B., Rodríguez, A. N., Carrasco, A. P., Cabezas, J. J. S., Cayuela, A., & Fernández, J. M. C. (2002) · Revista Española de Cardiología · doi:10.1016/s0300-8932(02)76569-x · Cited by 11
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citationHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Stroke prevention in atrial fibrillation
Freedman, B., Potpara, T. S., & Lip, G. Y. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31257-0 · Cited by 463
Metadata
- Authors
- Piccini, J. P., Simon, D. N., Steinberg, B. A., Thomas, L., Allen, L. A., Fonarow, G. C., Gersh, B., Hylek, E., Kowey, P. R., Reiffel, J. A., Naccarelli, G. V., Chan, P. S., Spertus, J. A., Peterson, E. D., & for the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients
- Venue
- JAMA Cardiology
- Publisher
- American Medical Association (AMA)
- Published
- 2016-06-01
- Volume
- 1
- Issue
- 3
- Pages
- 282
- ISSN
- 2380-6583 (ISSN-L)
- OpenAlex
- W2407343790
- Cited by
- 273
- References
- 26
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.